The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global fertility test market was valued at US$ 518.1 Million in 2022.
We expect the global fertility test market to exhibit a CAGR of 6.6% during 2023-2028.
The rising prevalence of Polycystic Ovary Syndrome (PCOS), along with the increasing stress and obesity among female working population, owing to their hectic lifestyles, is primarily driving the global fertility test market.
The sudden outbreak of the COVID-19 pandemic had led to the postponement of numerous elective fertility tests for reducing the risk of the coronavirus infection upon hospital visits and interaction with healthcare professionals or medical devices.
Based on the product, the global fertility test market has been divided into ovulation prediction kits, fertility monitors, and male fertility testing products. Currently, ovulation prediction kits exhibit a clear dominance in the market.
Based on the mode of purchase, the global fertility test market can be categorized into OTC-based and prescription-based, where OTC-based accounts for the majority of the global market share.
Based on the application, the global fertility test market has been segregated into female fertility testing and male fertility testing. Currently, female fertility testing currently holds the largest market share.
Based on the end user, the global fertility test market can be bifurcated into hospitals, home care settings, fertility clinics, and others. Among these, home care settings exhibit a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global fertility test market include Abbott Laboratories, AdvaCare Pharma, Ava AG, Babystart Ltd. (Snowden Healthcare), Church & Dwight Co. Inc., Fairhaven Health LLC, Geratherm Medical AG, Prestige Consumer Healthcare Inc., Quidel Corporation, UEBE Medical GmbH, Valley Electronics AG, and viO HealthTech Limited.
Infantile Spasms Therapeutics Market by Therapeutic Class (Anticonvulsants, Corticosteroids, and Others), Drug Type (Vigabatrin, Adrenocorticotropic Hormone, and Others (Phase III)), Dosage (Solid, Liquid), Route of Administration (Oral, Parenteral, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End User (Hospitals, Clinics, and Others), and Region 2023-2028
Hyperphosphatemia Drugs Market by Product (Sevelamer, Calcium Based Phosphate Binders, Iron Based Phosphate Binders, Lanthanum Carbonate, and Others), Dosage Form (Tablets, Syrups, Capsules), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2023-2028
Urology Robotic Surgery Market by Component (Robotic Surgery Systems, Instruments and Accessories, Services), Application (Robotic Prostatectomy, Robotic Cystectomy, Robotic Pyeloplasty, Robotic Nephrectomy, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at